← Back to Dashboard

Prezcobix

Protease inhibitor + CYP3A4 booster

Constituent drugs (2)

Darunavir

Could not render structureView on PubChem
3D not available

Cobicistat

Could not render structureView on PubChem
3D not available

Chemical Identifiers

ClinicalTrials.govPubMed

Clinical Development by Virus1

Human immunodeficiency virus 1
HIV-1
Target: Viral protease
Approved (other)
Preclinical
Phase 2positive
Phase 3positive
Approved
Japan
Approval ref (pmda.go.jp) PMDA approved Nov. 22, 2016fixed-dose combination of Darunavir, Cobicistat.